Preclinical and clinical evaluation of POONAI MEESAI CHOORANAM KUDINEER (Oral administration) in the management of NEPHROTIC SYNDROME

preclinical and clinical evaluation of the effect on oral administration of POONAI MEESAI CHOORANAM KUDINEER in the management of OOTHU SOBAI

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040774

Enrollment

Registered

2022-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes

Interventions

Intervention1: Poonai meesai chooranam kudineer: 15-30ML BD Before food For 30 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Oedema due to renal impairment

Exclusion criteria

Exclusion criteria: Children above 12 years Children below 3 years Hypothyroidism Cushing syndrome Oedema due to drug allergy Oedema mimics obesity in children Acute glomerular nephritis Chronic glomerular nephritis

Design outcomes

Primary

Measure	Time frame
REDUCTION IN SYMPTOMSTimepoint: 21 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr D K SOUNDARARAJAN MD S

Government Siddha Medical College and Hospital, Palayamkottai.

dr.dks2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026